Gasdermin A (GSDMA) (C-Term) Peptide
GSDMA
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Gasdermin A (GSDMA) products
- Gasdermin A (GSDMA)
- Protein Region
- C-Term
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ICNDNMQTFP PGEKSGEEKV ILIQASDVGD VHEGFRTLKE EVQRETQQVE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-GSDMA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Gasdermin A (GSDMA)
- Synonyms
- BB149167 Peptide, Gsdm Peptide, Gsdm1 Peptide, Gsdma1 Peptide, H312E Peptide, GSDM1 Peptide, GSDM Peptide, gasdermin A Peptide, Gsdma Peptide, GSDMA Peptide
- Background
-
GSDMA induces apoptosis.
Alias Symbols: FKSG9, FLJ39120, GSDM, GSDM1, MGC129596
Protein Size: 445 - Molecular Weight
- 49 kDa
- Gene ID
- 284110
- NCBI Accession
- NM_178171, NP_835465
- UniProt
- Q96QA5
-
You are here:
